Alcon Independent Director Committee Responds to Novartis
January 4, 2010 by Ann Deters
Filed under Alcon
HUENENBERG, Switzerland, Jan 04, 2010 (BUSINESS WIRE) — The Alcon, Inc. (NYSE: ACL) Independent Director Committee, in response to comments made today by Novartis AG (NYSE: NVS), stated its belief that Alcon has established certain important protections for the benefit of Alcon’s minority shareholders against a coercive takeover bid and is disappointed that Novartis is attempting to circumvent those protections and corporate governance best practices.
Alcon, a majority-controlled entity since it became a public company in 2002, established certain protections in its governing documents for the benefit of its minority shareholders. For example, Article V, Section 5 of Alcon’s Organizationa…
 |
A post by "Ann Deters" http://www.VantageOutsourcing.com Ann Deters passion is to be an advocate for hospitals and surgery centers, allowing them to maximize profits by providing cataract outsourcing services in an efficient and low cost manner. Ann, has been a columnist about health care issue for two decades writing for numerous health care magazines. |
